Literature DB >> 9492920

Diurnal periodicity of Leishmania amastigotes in peripheral blood of Indian Kala-azar patients.

R Saran1, M C Sharma, A K Gupta, S P Sinha, S K Kar.   

Abstract

Peripheral blood smears of 20 patients with Indian Kala-azar (KA) were collected throughout the day and night and examined for presence of Leishmania amastigotes. Amastigotes were detected in 46% of peripheral blood samples taken during the day (08:00-17:00 h) and 66% and during the night (18:00-07:00 h). This difference was statistically highly significant (P < 0.0001). The confirmation of amastigote diurnal periodicity is of interest, and the high percentage of parasitemic patients at night is likely to reflect the biting habit of the sandfly vector of Kala-azar Phlebotomus argentipes.

Entities:  

Mesh:

Year:  1997        PMID: 9492920     DOI: 10.1016/s0001-706x(97)00104-6

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

1.  Peripheral blood buffy coat smear: a promising tool for diagnosis of visceral leishmaniasis.

Authors:  M Abdus Salam; M Gulam Musawwir Khan; Khondaker Rifat Hasan Bhaskar; Mokibul Hassan Afrad; M Mamun Huda; Dinesh Mondal
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Alteration of Fas and Fas ligand expression during human visceral leishmaniasis.

Authors:  L Eidsmo; D Wolday; N Berhe; F Sabri; I Satti; A M El Hassan; S Sundar; F Chiodi; H Akuffo
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

Review 3.  The Complex Interplay of Parasites, Their Hosts, and Circadian Clocks.

Authors:  Priscilla Carvalho Cabral; Martin Olivier; Nicolas Cermakian
Journal:  Front Cell Infect Microbiol       Date:  2019-12-12       Impact factor: 5.293

4.  Parasitemia and its daily variation in canine leishmaniasis.

Authors:  Simona Di Pietro; Chiara Crinò; Annastella Falcone; Rosalia Crupi; Francesco Francaviglia; Fabrizio Vitale; Elisabetta Giudice
Journal:  Parasitol Res       Date:  2020-08-15       Impact factor: 2.289

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.